SENSEX NIFTY

Religare Capital Markets

Jul 25, 2014 at 18:46 | Source: Moneycontrol.com
Arihant capital markets has recommended a neutral rating on UltraTech Cement with a target price of Rs 2600, in its research report dated July 21, 2014.
Jul 25, 2014 at 18:45 | Source: Moneycontrol.com
Arihant capital markets has recommended a neutral rating on Bajaj Auto (BAL) in its research report. The research firm believes, export exposure will help the company to tide over weak domestic market.
Jul 25, 2014 at 15:52 | Source: CNBC
"With access to foreign capital likely to become more restrictive, the pick-up in investment needed to revive Russia`s ailing economy is starting to look ever more unlikely," Neil Shearing, chief emerging markets economist at Capital Economics, said in a note Thursday.
Jul 25, 2014 at 15:28 | Source: CNBC-TV18
Saurabh Mukherjea of Ambit Capital says the moves from hereon will be much measured in the junk stocks. They have actually outperformed the midcap and small caps.
Jul 25, 2014 at 15:18 | Source: Moneycontrol.com
Religare Capital is bullish on Ambuja Cements and has recommended buy rating on the stock with a target of Rs 255 in its July 24, 2014 research report.
Jul 25, 2014 at 15:16 | Source: Moneycontrol.com
Religare Capital is bullish on ACC and has recommended buy rating on the stock with a target of Rs 1610 in its July 24, 2014 research report.
Jul 25, 2014 at 13:25 | Source: Moneycontrol.com
Religare Capital has recommended hold rating on Wipro with a target price of Rs 625, in its research report dated July 24, 2014.
Jul 25, 2014 at 13:24 | Source: Moneycontrol.com
Religare Capital has recommended hold rating on Thermax with a target price of Rs 900, in its research report dated July 23, 2014.
Jul 25, 2014 at 13:09 | Source: CNBC-TV18
Punjab National Bank reported a jump of jumped 10.2 percent in its first quarter net profit to Rs 1,405 crore on account of fall in provisions on a year-on-year basis. But the decline in other income limited the profitability.
Jul 25, 2014 at 12:49 | Source: Moneycontrol.com
Religare Capital has recommended hold rating on Ipca Laboratories with a target price of Rs 835, in its research report dated July 24, 2014.
Messages on Religare Capital Markets »

Web Messenger

Platinum Member

229467 Followers

Indian indices  

Source:NDTV Profit - 2:30 p.m. Tirthankar Patnaik of Religare Capital Markets says that Nifty has could run up by another 100-150 points before the fundamentals catch up. (Track stocks). All the sectoral indices, except the pharma, are trading higher. Gail India, Tech

4.55 PM Mar 6th

cleverman

Platinum Member

91 Followers

Ranbaxy Labs  

also the stock will have a downside of around 10-15 per cent from these levels. We recommend a sell on the stock," adds Nangra. Arvind Bothra, Vice President, institutional research, Religare Capital Markets, says, "we expect significant negative impact on stock price following this news and reiterate

8.15 PM Jan 24th

BSE/NSE Announcer

Platinum Member

3551 Followers

Crompton Greave  

"). This Advertisement should be read in conjunction with, and in continuation of, the Public Announcement (PA") published on July 04, 2013 and corrigenda to the PA published on July 16, 2013 and November 09,2013 to the shareholders of Crompton Greaves Limited ("Target Company")Religare Capital Markets Ltd

5.45 PM Jan 16th

Web Messenger

Platinum Member

229467 Followers

Ipca Labs  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

229467 Followers

Glenmark  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

229467 Followers

News Now  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on market movement in 2014. ET Now: Last day of 2013, how does that really set stage for what your outlook is in the initial part

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

229467 Followers

Infosys  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on Infosys. ET Now: What makes you bullish on Infosys? Dr Tirthankar Patnaik: We are positive on the whole IT sector and therefore

3.25 PM Dec 31st 2013

DLF  

The central bank will hike repo rate, or the rate at which banks borrow from the central bank (Reserve Bank of India), by a total of 50 basis points (bps) till FY14-end, believes Tirthankar Patnaik, executive vice president- institutional sales, Religare Capital Markets. So it will sock to real

11.52 AM Oct 25th 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.47 PM Oct 23rd 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.46 PM Oct 23rd 2013

News across the web »
Jul 08, 2014 at 07:59 | Source: FirstPost
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.